BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758 AND Treatment
15 results:

  • 1. Investigation of iso-propylchaetominine anticancer activity on apoptosis, cell cycle and Wnt signaling pathway in different cancer models.
    Karamad V; Sogutlu F; Ozkaya FC; Shademan B; Ebrahim W; El-Neketi M; Avci CB
    Fitoterapia; 2024 Mar; 173():105789. PubMed ID: 38158162
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A CT-Based Radiomics Model for Evaluating Peritoneal cancer Index in Peritoneal Metastasis Cases: A Preliminary Study.
    Zhang Q; Yuan Y; Li S; Li Z; Jing G; Lu J; Shao C; Hao Q; Lu Y; Shen F
    Acad Radiol; 2023 Jul; 30(7):1329-1339. PubMed ID: 36180327
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Early drug development in solid tumours: analysis of National cancer Institute-sponsored phase 1 trials.
    Chihara D; Lin R; Flowers CR; Finnigan SR; Cordes LM; Fukuda Y; Huang EP; Rubinstein LV; Nastoupil LJ; Ivy SP; Doroshow JH; Takebe N
    Lancet; 2022 Aug; 400(10351):512-521. PubMed ID: 35964611
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Computed Tomography-based Radiomics Evaluation of Postoperative Local Recurrence of pancreatic Ductal Adenocarcinoma.
    He M; Chen X; Wels M; Lades F; Li Y; Liu Z; Jin Z; Xue H
    Acad Radiol; 2023 Apr; 30(4):680-688. PubMed ID: 35906151
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A Novel Prognostic Signature Revealed the Interaction of Immune Cells in Tumor Microenvironment Based on Single-Cell RNA Sequencing for Lung Adenocarcinoma.
    Jin X; Hu Z; Sui Q; Zhao M; Liang J; Liao Z; Zheng Y; Wang H; Shi Y
    J Immunol Res; 2022; 2022():6555810. PubMed ID: 35812244
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Determining oncogenic patterns and cancer predisposition through the transcriptomic profile in Mitchell-Riley syndrome with heterotopic gastric mucosa and duodenal atresia: a case report.
    Calcaterra V; Chiricosta L; Mazzon E; Gugnandolo A; Alberti D; Maestri L; Meroni M; Vestri E; Verduci E; Dilillo D; Zuccotti G; Pelizzo G
    Orphanet J Rare Dis; 2021 Oct; 16(1):455. PubMed ID: 34715892
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Assessment of Modifiable Factors for the Association of Marital Status With cancer-Specific Survival.
    Chen ZH; Yang KB; Zhang YZ; Wu CF; Wen DW; Lv JW; Zhu GL; Du XJ; Chen L; Zhou GQ; Liu Q; Sun Y; Ma J; Xu C; Lin L
    JAMA Netw Open; 2021 May; 4(5):e2111813. PubMed ID: 34047792
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic pancreatic Adenocarcinoma.
    Botrus G; Kosirorek H; Sonbol MB; Kusne Y; Uson Junior PLS; Borad MJ; Ahn DH; Kasi PM; Drusbosky LM; Dada H; Surapaneni PK; Starr J; Ritter A; McMillan J; Wylie N; Mody K; Bekaii-Saab TS
    Oncologist; 2021 Jul; 26(7):569-578. PubMed ID: 33555095
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Real-Time Targeted Genome Profile Analysis of pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers.
    Singhi AD; George B; Greenbowe JR; Chung J; Suh J; Maitra A; Klempner SJ; Hendifar A; Milind JM; Golan T; Brand RE; Zureikat AH; Roy S; Schrock AB; Miller VA; Ross JS; Ali SM; Bahary N
    Gastroenterology; 2019 Jun; 156(8):2242-2253.e4. PubMed ID: 30836094
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Efficacy and safety of sunitinib in Japanese patients with progressive, advanced/metastatic, well-differentiated, unresectable pancreatic neuroendocrine tumors: final analyses from a Phase II study.
    Ito T; Tori M; Hashigaki S; Kimura N; Sato K; Ohki E; Sawaki A; Okusaka T
    Jpn J Clin Oncol; 2019 Apr; 49(4):354-360. PubMed ID: 30834940
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A novel role of the tumor size in pancreatic cancer as an ancillary factor for predicting resectability.
    Chiang KC; Lee CH; Yeh CN; Ueng SH; Hsu JT; Yeh TS; Jan YY; Hwang TL; Chen MF
    J Cancer Res Ther; 2014; 10(1):142-6. PubMed ID: 24762501
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Cervical esophageal perforations at the time of endoscopic ultrasound: a prospective evaluation of frequency, outcomes, and patient management.
    Eloubeidi MA; Tamhane A; Lopes TL; Morgan DE; Cerfolio RJ
    Am J Gastroenterol; 2009 Jan; 104(1):53-6. PubMed ID: 19098849
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Hedgehog signaling pathway and gastrointestinal stem cell signaling network (review).
    Katoh Y; Katoh M
    Int J Mol Med; 2006 Dec; 18(6):1019-23. PubMed ID: 17089004
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer.
    Zhu AX; Clark JW; Ryan DP; Meyerhardt JA; Enzinger PC; Earle CC; Fuchs CS; Regan E; Anbe H; Houghton M; Zhang J; Urrea P; Kulke MH
    Cancer Chemother Pharmacol; 2007 Feb; 59(3):285-93. PubMed ID: 16786333
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. pancreatic cancer, blood glucose and beverage consumption.
    Hiatt RA; Klatsky AL; Armstrong MA
    Int J Cancer; 1988 Jun; 41(6):794-7. PubMed ID: 3372055
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.